Rosetta Genomics to Present at the Annual Needham and Company Biotechnology and Medical Technology Conference
ROSG | Quote | Chart | News | PowerRating -- Rosetta Genomics, a molecular diagnostic company leveraging microRNAs as biomarkers, announced that Amir Avniel, president and chief executive officer, will be presenting a corporate update at the Eighth Annual Needham and Company Biotechnology and Medical Technology Conference on Wednesday, June 10, at 8:30 a.m., (Eastern Daylight Time) at the New York Palace Hotel.
A live webcast of the presentation will be available by going to the investor relations section of rosettagenomics.com and clicking on the link to Live Webcasts. An archived replay will be available for a period of 30 days.
((Comments on this story may be sent to health@closeupmedia.com))
For full details on Rosetta Genomics Ltd Ord (ROSG) ROSG. Rosetta Genomics Ltd Ord (ROSG) has Short Term PowerRatings at TradingMarkets. Details on Rosetta Genomics Ltd Ord (ROSG) Short Term PowerRatings is available at This Link.
- Rosetta Genomics: U.S. Patent Office Allows 2 Claims - 02/08/10
- Rosetta Genomics Announces Issuance of Three U.S. Patents - 02/03/10
- Rosetta Genomics Gets U.S. Allowance of Claims for 2 Patent Applications - 02/03/10
- BiomedReports: News and FDA Updates for Repligen (Nasdaq:RGEN), Rosetta (NASDAQ:ROSG), Senomyx (NASDAQ:SNMX) - 02/01/10
- Associatesfortune.com: Smokefree Innotec, Inc. & Rosetta Genomics - 01/29/10
- More News >>


